Joan Solanes Mullor: ‘Linking the EU and National Agencification Processes: A Growing Need to Overcome Inconsistencies’ (13 July 2017) The Agencification process in Europe presents two dimensions: the EU and national levels. Over the last two decades, the EU has
Linking the EU and National Agencification Processes: A Growing Need to Overcome Inconsistencies
By Joan Solanes Mullor The two dimensions of the agencification process in Europe The Agencification process in Europe presents two dimensions: the EU and national levels. Over the last two decades, the EU has relied on agencies to exercise its
TARN is participating in the Summer School ‘EU and Legal Reform’ in Montenegro
TARN will take part in the “EU and Legal Reform” summer school in Herceg Novi, Montenegro that takes place from 10-14 July. The summer school is organized by the Center for Constitutional Studies and Democratic Development (CCSDD) and Institute of
New TARN Blog on the External Dimension of EU Agencies and Bodies
Merijn Chamon, Sabrina Wirtz and Jacopo Alberti: ‘The External Dimension of EU Agencies and Bodies’ (6 July 2017) On 27 and 28 June 2017 the University of Luxembourg hosted the TARN Conference on the External dimension of EU agencies and
External Dimension of EU Agencies and Bodies
by Merijn Chamon, Sabrina Wirtz and Jacopo Alberti On 27 and 28 June 2017 the University of Luxembourg hosted the TARN Conference on the External dimension of EU agencies and bodies, organized by professors Herwig Hofmann, Ellen Vos, Morten Egeberg
New Blog: Carlo Tovo on the Relocation of EU Agencies after Brexit
Carlo Tovo: ‘The Procedure for Relocating EU Agencies after Brexit’ (2 July 2017) After the UK citizens voted to leave the EU in the 23 June 2016 referendum, it was clear from the outset (although perhaps not to the UK
The Procedure for Relocating EU Agencies after Brexit: An Encouraging Precedent?
By Carlo Tovo Background After the UK citizens voted to leave the EU in the 23 June 2016 referendum, it was clear from the outset (although perhaps not to the UK government) that the European Medicines Agency (EMA) and the